StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
Publishing Date
2024 - 03 - 25
7
2024 - 01 - 08
7
2024 - 01 - 04
7
2023 - 12 - 04
8
2023 - 11 - 28
8
2023 - 10 - 24
7
2023 - 09 - 20
7
2023 - 09 - 14
7
2023 - 09 - 05
7
2023 - 08 - 15
7
2022 - 12 - 06
7
2022 - 10 - 20
8
2022 - 10 - 11
8
2022 - 05 - 19
9
2022 - 04 - 12
9
2022 - 03 - 29
9
2022 - 03 - 22
7
2022 - 03 - 02
9
2022 - 01 - 25
11
2022 - 01 - 11
11
2022 - 01 - 05
12
2022 - 01 - 04
7
2021 - 12 - 16
7
2021 - 11 - 09
9
2021 - 10 - 26
7
2021 - 10 - 25
8
2021 - 10 - 18
8
2021 - 10 - 13
8
2021 - 10 - 12
7
2021 - 09 - 28
12
2021 - 09 - 27
7
2021 - 09 - 23
7
2021 - 09 - 21
9
2021 - 09 - 13
10
2021 - 09 - 08
9
2021 - 08 - 02
7
2021 - 07 - 15
7
2021 - 07 - 08
8
2021 - 07 - 06
7
2021 - 06 - 29
8
2021 - 06 - 24
8
2021 - 06 - 23
7
2021 - 06 - 17
8
2021 - 06 - 10
11
2021 - 06 - 02
7
2021 - 05 - 25
7
2021 - 05 - 06
9
2021 - 04 - 27
9
2021 - 04 - 13
8
2021 - 04 - 12
6
2021 - 04 - 07
8
2021 - 03 - 22
7
2021 - 03 - 16
6
2021 - 03 - 01
6
2021 - 02 - 02
6
2021 - 02 - 01
7
2021 - 01 - 19
8
2021 - 01 - 12
7
2021 - 01 - 05
6
2020 - 12 - 17
6
Sector
Health services
1
Health technology
10
Manufacturing
1
Tags
Alliances
1
Aramchol
1
Awards
1
Biocanada
1
Bioscience
3
Biotech-bay
4
Biotech-beach
2
Biotechnology
5
Cancer
1
Children
1
Clearance
2
Clinical-trials-phase-ii
4
Collaboration
11
Commercialization
3
Cystic fibrosis
1
Designation
1
Diagnostic
2
Diagnostics
1
Dialysis
1
Disease
3
Drug
2
Earnings
8
Enroll
2
Europe
5
Events
4
Expansion
1
Eye
1
Fda-approvals
1
Fibrosis
1
Food
1
Gene therapy
1
Genetown
3
Glioblastoma
1
Grant
1
Granted
1
License
3
Market
2
Milestone
8
Money
2
N/a
119
Nasdaq
2
New drug
2
People
9
Pharm-country
5
Phase 1
2
Phase 2
4
Positive
4
Potential
2
Research
13
Response
2
Risk
2
Sars-cov-2
3
System
2
T-cell
2
Test
3
Therapeutics
5
Therapy
5
Train
2
Treatment
3
Trial
4
Entities
Aligos therapeutics, inc.
1
Allogene therapeutics, inc.
1
Amgen inc.
1
Atara biotherapeutics, inc.
1
Beigene, ltd.
1
Evotec se
2
Evotec se - adr
1
Fusion pharmaceuticals inc.
2
Invitae corporation
1
Nektar therapeutics
1
Pacific biosciences of california, inc.
1
Symbols
ALGS
1
ALLO
1
AMGN
1
ATRA
1
BGNE
1
EVO
1
EVOTF
2
FUSN
2
NKTR
1
NVTA
1
PACB
1
Exchanges
Nasdaq
10
Nyse
1
Crawled Date
2022 - 01 - 11
11
Crawled Time
11:00
1
12:30
1
13:30
2
15:00
5
15:30
1
17:00
1
Source
www.biospace.com
10
www.globenewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2022 - 01 - 11
tags :
Collaboration
save search
$1 Billion Pfizer-Dren Bio Deal Highlights Another Day of Collaborations
Published:
2022-01-11
(Crawled : 17:00)
- biospace.com/
EVOTF
|
$21.68
30.35%
3.2K
|
Health Technology
|
Email alert
Add to watchlist
collaboration
Aligos Therapeutics Expands Collaboration with Merck to Develop Oligonucleotide Therapies for NASH
Published:
2022-01-11
(Crawled : 15:30)
- biospace.com/
ALGS
|
$0.839
4.74%
4.53%
97K
|
Health Technology
|
-78.02%
|
O:
2.68%
H:
0.0%
C:
0.0%
therapy
collaboration
AMGEN AND ARRAKIS THERAPEUTICS ANNOUNCE MULTI-TARGET COLLABORATION TO IDENTIFY NOVEL RNA DEGRADER SMALL MOLECULE THERAPEUTICS
Published:
2022-01-11
(Crawled : 15:00)
- biospace.com/
BGNE
|
$139.22
6.32%
5.95%
200K
|
Health Technology
|
-39.83%
|
O:
1.58%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
19.53%
|
O:
0.71%
H:
0.0%
C:
0.0%
therapeutics
collaboration
Allogene Therapeutics Announces Exclusive Collaboration and Global License Agreement with Antion Biosciences for Multiplex miCAR™ Technology
Published:
2022-01-11
(Crawled : 15:00)
- biospace.com/
ALLO
|
$3.365
-1.03%
-1.04%
1.6M
|
Health Technology
|
-72.38%
|
O:
1.89%
H:
0.0%
C:
0.0%
license
bioscience
collaboration
Fusion Pharmaceuticals Announces Research Collaboration with Pepscan to Develop Peptide-Based Radiopharmaceuticals
Published:
2022-01-11
(Crawled : 15:00)
- biospace.com/
FUSN
|
$21.42
0.47%
0.47%
1.9M
|
Health Technology
|
333.6%
|
O:
11.34%
H:
0.0%
C:
0.0%
collaboration
BigHat Biosciences Completes First Stage of Research Collaboration with Amgen
Published:
2022-01-11
(Crawled : 15:00)
- biospace.com/
NKTR
|
News
|
$1.415
4.04%
3.89%
1.1M
|
Health Technology
|
-88.96%
|
O:
-0.08%
H:
0.0%
C:
0.0%
research
bioscience
collaboration
Imeka Collaborates with Atara Biotherapeutics to Provide Neuroimaging for Phase 2 Study in Multiple Sclerosis
Published:
2022-01-11
(Crawled : 15:00)
- biospace.com/
ATRA
|
$0.7199
3.23%
3.13%
830K
|
Health Technology
|
-95.47%
|
O:
-2.46%
H:
0.0%
C:
0.0%
phase 2
sclerosis
collaboration
multiple sclerosis
Fusion Pharmaceuticals Announces Research Collaboration with 48Hour Discovery to Develop Peptide-Based Radiopharmaceuticals
Published:
2022-01-11
(Crawled : 13:30)
- biospace.com/
FUSN
|
$21.42
0.47%
0.47%
1.9M
|
Health Technology
|
333.6%
|
O:
11.34%
H:
0.0%
C:
0.0%
collaboration
PacBio Announces Record Preliminary Fourth Quarter 2021 Revenue, New Sequencing Kits and Workflows, and Expanded Collaborations
Published:
2022-01-11
(Crawled : 13:30)
- biospace.com/
NVTA
|
News
|
$0.019
0.0%
22M
|
Health Services
|
-99.84%
|
O:
0.33%
H:
0.0%
C:
0.0%
collaboration
PacBio Announces Collaboration with Genomics England to Sequence Biobanked Rare Disease Samples Using HiFi Sequencing Technology
Published:
2022-01-11
(Crawled : 12:30)
- globenewswire.com
PACB
|
$1.465
-6.09%
-6.48%
9.7M
|
Health Technology
|
-91.13%
|
O:
-13.48%
H:
0.0%
C:
0.0%
disease
collaboration
rare
Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include New Targeted Protein Degradation Approach
Published:
2022-01-11
(Crawled : 11:00)
- biospace.com/
EVO
|
$7.69
4.48%
4.29%
34K
|
Manufacturing
|
-62.61%
|
O:
5.87%
H:
0.0%
C:
0.0%
collaboration
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.